We investigated the influences of difructose anhydride III (DFAIII), a novel commercially available disaccharide, on sugar metabolism, breath hydrogen and serum ace tate in the early stages after ingestion to determine whether DFAIII is an indigestible sugar and to what degree it is fermentable in humans. This study was designed as a randomized controlled single-blind crossover test with 9 healthy subjects, who drink a 200mL water solution containing 10g of DFAIII, lactulose or sucrose following overnight fasting. Blood samples (for analysis of glucose, fructose, insulin, triacylglycerol, free fatty acids, and ace tate) were collected at 0, 0.5, 1, 2, 4, 8h after the ingestion and breath samples (for analysis of hydrogen and methane gases) were collected at 1h intervals until 8h after the ingestion. We also interviewed each subject hourly about the incidence and severity of specific abdom inal complaints and other symptoms. The results revealed that ingestion of 10g of DFAIII did not change the serum levels of glucose, fructose, and insulin, similarly to the case with lactulose, and no increase in breath hydrogen excretion was comparable to the case with sucrose. The incidence of specific abdominal symptoms tended to be lower after DFAIII inges tion than after lactulose ingestion. It thus turned out that DFAIII was indigestible and low fermentable in the early stages after ingestion.
peripheral blood (acetate). The fermentability of ingested indigestible saccharides is well reflected in the breath hydrogen level, since enterobacteria alone pro duce hydrogen excreted in the breath (11). Thus it can be used as an indication of predicting the fermentability of indigestible saccharides in humans (12-21).
Although venous acetate appears to be less sensitive than breath hydrogen (17), a stable-isotope method has been used to quantitatively measure acetate production (16) , and several studies are based on the blood venous acetate level (16-18, 20, 21) . In this study, we measured breath hydrogen, meth ane, and serum acetate to evaluate the fermentability of DFAIII, and blood parameters related to sugar and fat metabolism to evaluate its digestibility. Data was com pared to those of lactulose and sucrose. of the FANCL Co., Ltd, and 10 subjects first agreed to take part in the study. We informed all participants as to the purpose and plan of this study as well as their rights to resign at their own will and our duties to guard their personal privacies against outsiders, from whom the informed consents were obtained in writing. We con fi rmed by questionnaires that all subjects did neither have any chronic gastrointestinal disorders including diarrhea nor disorders of the viscera (liver, kidney, pan creas, etc.) nor dosage of antibiotics over 10d before the start of the study. Prior to the initiation of the study, one male subject was forced to drop out owing to pressure of business. One female subject left the study after the start due to a pregnancy. The remaining 8 subjects were able to follow our experimental protocol without prob lems. The mean age of the remaining 8 subjects was 28 years old in the range of 23 to 32. 3. Study design. This study was designed as a ran domized controlled single-blind crossover test. Subjects followed the meal plan shown in 
RESULTS
Physical characteristics of the subjects taking part in this experiment throughout its period are presented in Table 2 . There were no significant differences among the three groups in those respects.
After ingestion of DFAIII, a female subject suffered from watery diarrhea, while two female subjects had a loose passage and a male subject suffered from watery diarrhea after ingestion of lactulose. The same female subject suffered from diarrhea different in manifesta tion by ingestion of DFAIII and lactulose, respectively. No subjects suffered from diarrhea after ingestion of sucrose.
Serum glucose, fructose, and insulin levels were ele vated at 0.5h after sucrose ingestion as compared to those before ingestion. There were no changes in these parameters at the same times after DFAIII or lactulose ingestion (Fig. 2) . Both serum glucose levels at 0.5h after ingestion of DFAIII and lactulose were lower than that after sucrose ingestion. Similar tendencies were also observed for serum fructose levels. There was no significant difference at each time point between both cases of DFAIII and lactulose ingestion. None of the subjects exhibited methane values over 2ppm in their breath (data not shown). Breath hydro gen tended to increase gradually and reach a maximum at 3h after ingestion of lactulose, while there were no changes up to 8h in both cases of DFAIII and sucrose (Fig. 3) . The difference in breath hydrogen between both cases of DFAIII and lactulose became significant at 3h, thenceforth lasting until 8h. The incremental area under the curve (AUC) for breath hydrogen over a period of 8h was far low after ingestion of DFAIII or sucrose as compared to that after ingestion of lactulose. There were no changes in serum acetate, FFA, and TG levels in case of any disaccharide ingestion at all elapsed time points The subjects in case of DFAIII ingestion were less annoyed at gastrointestinal symptoms than in case of lactulose ingestion (Fig. 4) . The incidence of abdominal pain and anorexia was actualized only when they ingested lactulose. Four subjects reported the incidence of rumbling in the intestine after ingestion of lactulose, whereas a subject or two complained of rumbling or distention after ingestion of DFAIII. These symptoms were regarded as mild or moderate. No subject seemed aware of any gastrointestinal symptoms after ingestion of sucrose. There were no other adverse events through out this study.
DISCUSSION
The objective of this study was to examine the effects of DFAIII on sugar metabolism or enterobacterial fer mentation in humans. We observed no changes in serum glucose, fructose, and insulin levels after inges tion of DFAIII in contrast to their elevations seen after ingestion of sucrose. It can be postulated from these results that DFAIII is an indigestible saccharide. More over, the subjects dosed with DFAIII showed no increase in breath hydrogen, which was in marked contrast to the increased hydrogen excretion in case of lactulose ingestion; indicating that DFAIII is not as fermentable as lactulose.
Indigestible saccharides pass through the small intes tine and reach the colon in their intact form, which undergo fermentation by the acting of enterobacteria and produce hydrogen, methane, and SCFA. In this respect, DFAIII had a characteristic of the indigestible saccharides despite little fermentability relative to a familiar fermentable disaccharide "lactulose" (16, 17, 19, 26, 27) . Such an indigestible saccharide as reduced palatinose (12) seems to be almost completely fer mented within 6h in the human intestine (19) . Also the increased breath hydrogen excretion occurs rapidly after ingestion of fructo-oligosaccharide (a mixture of tri to penta-saccharides) (13), maltitol (reduced disac charide) (14) and D-tagatose (monosaccharide) (15) . The present study suggests that DFAIII may be the least fermentable of already known indigestible mono or oligo-saccharides. The in vitro studies using the Ussing chamber technique have demonstrated that DFAIII directly enhances calcium absorption from the small and large intestines in its intact form (8, 9). Thus the relatively higher resistance of DFAIII to enterobactterial fermentation can put its stimulating effect on calcium absorption into practice. However, a previous animal experiment implies that the feeding of a 3% DFAIII diet for 3wk induces higher SCFA levels and lower pH in the cecum than those seen with the diet deprived of DFAIII (7). Another study suggests that the ingestion of slightly digestible cornstarch causes no increases in breath hydrogen and serum acetate concentration within 8h but elevates both parameters at 10-13h than that seen with easily digestible starch (18) . In this analogy, DFAIII fermentation may occur at later stages after its ingestion or exactly by adaptation of enterobac teria to DFAIII. The low fermentability of DFAIII in early stages after ingestion may possibly result from its unique structure with two glycoside linkages (Fig. 1) . This possibility needs to be clarified in the future.
Although breath hydrogen level after ingestion of lactulose was significantly higher than that seen after ingestion of DFAIII or sucrose, there was no significant difference in serum acetate level between both cases at each elapsed time. There are a few published reports on an indication of peripheral venous acetate for monitor ing events in the large bowel (20) , although breath hydrogen seems to be more frequent. It has been dem onstrated that blood acetate level increases after oral ingestion of 20g of lactulose (16) . In another study, the subjects who ingested 20g of lactulose had a higher incremental AUC for serum acetate than those who ingested 20g of sorbitol (17) . Thus the dosage of lactu lose adopted in this study may have been too low to increase peripheral serum acetate level especially in the 5 subjects not exhibiting increase after lactulose inges tion. However, the incremental change in AUC for serum acetate after ingestion of lactulose was higher than that seen after ingestion of sucrose; indicating that the parameter would reflect the fermentation of lactu lose to a certain extent.
With the exception of a decreased tendency of FFA at 1h after ingestion of sucrose, which is probably due to the raised blood sugar level, the FFA and TG levels remained unchangeable after ingestion of the samples; 
